This Week at FDA: PreCheck Manufacturing Program, New FDA Chief Counsel, and MoreAugust 8, 2025August 15, 2025
This Week at FDA: Prasad’s Exit from CBER, 7-OH Scheduling, Updated Opioid LabelingAugust 1, 2025August 8, 2025